- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-11-0003085

About Star Imaging and Path Lab Limited
Data last updated:
Star Imaging and Path Lab Limited is a public limited company based in New Delhi, Delhi, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 31 May 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN L85110DL2004PLC126679. The company has 2 GST registrations on record, none of which is active. It is a listed company as per MCA records. Its shares are listed on BSE: 544482.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹17.42 Cr. It is led by directors including Pawan Gupta (Managing Director) and Neelam Ratra.
Its last annual general meeting (AGM) was held on 24 July 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 4B/4 Tilak Nagar Near Sant Pura, New Delhi, Delhi, India – 110018.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹88.53 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹19.29 Cr (net margin 21.8%) and EBITDA of ₹33.17 Cr (EBITDA margin 37.5%). The net worth stands at ₹116.1 Cr (up 146.2% YoY). Total assets are valued at ₹137.66 Cr (up 70.4% YoY).
The company has about 13 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹24.1 Cr and satisfied charges of ₹38.68 Cr on record. Court records list 5 cases involving the company, including 4 filed by the company and 1 filed against it; 1 case is pending. The company has 9 deals on record (3 secondary share transfers, 3 market trades, 2 funding rounds), with disclosed funding of ₹1.49 Cr; the latest was in June 2026. Its 3 peer companies in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities) are compared by revenue, 1 larger and 2 smaller; the largest is Atulaya Healthcare Private Limited with revenue of ₹85.65 Cr.
Star Imaging and Path Lab Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0003085). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website starimaging.in.
Company details
CIN history
Star Imaging and Path Lab has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L85110DL2004PLC126679, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85110DL2004PLC126679 | Current |
| U85110DL2004PLC126679 | Previous |
| U85110DL2004PTC126679 | Previous |
Recognitions & Rankings of Star Imaging and Path Lab
Contact details
Star Imaging and Path Lab Limited's registered office is in New Delhi, Delhi.
- Social Media
- Registered Address4B/4 Tilak Nagar Near Sant Pura, New Delhi, Delhi, India – 110018
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Star Imaging and Path Lab is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Star Imaging and Path Lab Limited, buy the company report.
Financials of Star Imaging and Path Lab Limited
FY 2025-26 filings availableStar Imaging and Path Lab Limited reported revenue of ₹88.53 Cr (up 6% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 88.53 | 83.50 | 78.78 | 58.53 | 69.09 |
| Revenue growth | +6.0% | +6.0% | +34.6% | -15.3% | - |
| EBITDA | 33.17 | 29.34 | 23.19 | 6.05 | 14.70 |
| EBITDA margin | +37.5% | +35.1% | +29.4% | +10.3% | +21.3% |
| Profit before tax | 26.27 | 21.44 | 16.12 | 0.89 | 9.40 |
| Net profit | 19.29 | 15.94 | 11.66 | 0.58 | 6.30 |
| Net profit margin | +21.8% | +19.1% | +14.8% | +1.0% | +9.1% |
| EPS (₹) | 11.05 | 11.80 | 82.78 | 3.86 | 41.94 |
| Balance sheet | |||||
| Total assets | 138 | 80.79 | 62.83 | 46.32 | 48.62 |
| Net worth | 116 | 47.15 | 31.35 | 18.93 | 18.36 |
| Total debt | 20.67 | 32.74 | 30.63 | 26.56 | 29.57 |
| Cash & bank | 51.61 | 5.35 | 15.71 | 2.35 | 9.05 |
| Net working capital | 100 | 50.94 | 35.51 | 12.40 | 23.19 |
| Cash flow | |||||
| Cash from operations | 23.34 | (2.63) | 18.34 | 5.27 | 14.40 |
| Cash from investing | (12.75) | (7.36) | (6.87) | (7.22) | (4.14) |
| Cash from financing | 35.67 | (0.37) | 1.89 | (4.74) | (6.98) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 88.53 | 83.24 | 78.50 | 58.37 | 68.94 |
| Revenue growth | +6.4% | +6.0% | +34.5% | -15.3% | - |
| EBITDA | 33.23 | 28.56 | 22.52 | 6.02 | 14.68 |
| EBITDA margin | +37.5% | +34.3% | +28.7% | +10.3% | +21.3% |
| Profit before tax | 26.33 | 21.34 | 16.01 | 0.87 | 9.41 |
| Net profit | 19.33 | 15.92 | 11.59 | 0.57 | 6.31 |
| Net profit margin | +21.8% | +19.1% | +14.8% | +1.0% | +9.2% |
| EPS (₹) | 11.09 | 11.79 | 82.25 | 3.82 | 42.01 |
| Balance sheet | |||||
| Total assets | 138 | 80.62 | 62.70 | 46.30 | 48.56 |
| Net worth | 116 | 47.06 | 31.27 | 18.93 | 18.36 |
| Total debt | 20.67 | 32.74 | 30.63 | 26.56 | 29.52 |
| Cash & bank | 51.51 | 5.14 | 15.44 | 2.18 | 8.97 |
| Net working capital | 100 | 50.75 | 35.37 | 12.39 | 23.12 |
| Cash flow | |||||
| Cash from operations | 23.44 | (2.49) | 18.25 | 6.47 | 14.39 |
| Cash from investing | (12.75) | (7.44) | (6.87) | (8.57) | (4.14) |
| Cash from financing | 35.67 | (0.37) | 1.89 | (4.70) | (6.99) |
Financial Statements
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Revenue | 88.53 | 83.50 | 78.78 | 58.53 | 69.09 |
| Revenue growth | +6.0% | +6.0% | +34.6% | -15.3% | - |
| Other income | 1.00 | 0.29 | 1.19 | 0.15 | 0.18 |
| Total expenses | 55.36 | 54.16 | 55.59 | 52.48 | 54.39 |
| Employee cost | 0.00 | 7.49 | 7.24 | 8.31 | 8.90 |
| EBITDA | 33.17 | 29.34 | 23.19 | 6.05 | 14.70 |
| EBITDA margin | +37.5% | +35.1% | +29.4% | +10.3% | +21.3% |
| Depreciation | 5.93 | 4.96 | 5.24 | 3.34 | 3.53 |
| Interest | 1.97 | 3.23 | 3.02 | 1.97 | 1.95 |
| Profit before tax | 26.27 | 21.44 | 16.12 | 0.89 | 9.40 |
| Tax | 7.00 | 5.47 | 3.66 | 0.31 | 3.09 |
| Net profit | 19.29 | 15.94 | 11.66 | 0.58 | 6.30 |
| Net profit margin | +21.8% | +19.1% | +14.8% | +1.0% | +9.1% |
| EPS (₹) | 11.05 | 11.80 | 82.78 | 3.86 | 41.94 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Equity & liabilities | |||||
| Share capital | 17.42 | 13.50 | 1.50 | 1.50 | 1.50 |
| Reserves & surplus | 98.68 | 33.65 | 29.85 | 17.43 | 16.86 |
| Shareholders' funds (net worth) | 116 | 47.15 | 31.35 | 18.93 | 18.36 |
| Minority interest | 0.05 | 0.08 | 0.05 | 0.01 | 0.01 |
| Secured loans | 5.70 | 13.65 | 11.41 | 10.75 | 11.74 |
| Unsecured loans | 14.97 | 19.09 | 19.22 | 15.81 | 17.83 |
| Total debt | 20.67 | 32.74 | 30.63 | 26.56 | 29.57 |
| Total liabilities | 138 | 80.79 | 62.83 | 46.32 | 48.62 |
| Assets | |||||
| Gross block | 78.71 | 68.47 | 64.35 | 56.41 | 49.11 |
| Net block | 25.22 | 20.91 | 21.70 | 19.01 | 15.05 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.38 | 0.24 | 0.53 | 0.63 | 0.08 |
| Sundry debtors | 49.93 | 50.76 | 32.64 | 17.61 | 16.16 |
| Cash & bank balances | 51.61 | 5.35 | 15.71 | 2.35 | 9.05 |
| Loans & advances | 12.88 | 10.89 | 4.39 | 5.56 | 6.30 |
| Total current assets | 115 | 67.24 | 53.27 | 26.15 | 31.59 |
| Total current liabilities | 14.64 | 16.30 | 17.76 | 13.75 | 8.40 |
| Net working capital | 100 | 50.94 | 35.51 | 12.40 | 23.19 |
| Total assets | 138 | 80.79 | 62.83 | 46.32 | 48.62 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Opening cash | 5.35 | 15.71 | 2.35 | 9.05 | 5.77 |
| Net cash from operating activities | 23.34 | (2.63) | 18.34 | 5.27 | 14.40 |
| Net cash from investing activities | (12.75) | (7.36) | (6.87) | (7.22) | (4.14) |
| Net cash from financing activities | 35.67 | (0.37) | 1.89 | (4.74) | (6.98) |
| Net change in cash | 46.26 | (10.37) | 13.36 | (6.69) | 3.28 |
| Closing cash | 51.61 | 5.35 | 15.71 | 2.35 | 9.05 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Growth | |||||
| Sales growth | +6.0% | +6.0% | +34.6% | -15.3% | - |
| EBITDA growth | +13.1% | +26.5% | +283.3% | -58.8% | - |
| PBT growth | +22.5% | +33.0% | +1711.2% | -90.5% | +9997.0% |
| Net income growth | +21.0% | +36.7% | +1910.3% | -90.8% | - |
| Revenue CAGR (3Y) | +14.8% | +6.5% | - | - | - |
| EBITDA CAGR (3Y) | +76.3% | +25.9% | - | - | - |
| Profitability & leverage | |||||
| Net income margin | +21.8% | +19.1% | +15.8% | +1.0% | +9.1% |
| Return on capital employed | - | +34.4% | +35.1% | +6.0% | +23.3% |
| Return on net worth | - | +40.7% | +49.5% | +3.1% | +34.3% |
| Debt / equity | - | 0.81 | 1.14 | 1.50 | 1.61 |
| Long-term debt / equity | - | 0.39 | 0.60 | 0.83 | 0.91 |
| Interest cover | 7.23 | 13.25 | 16.82 | 72.69 | 17.46 |
| Efficiency & per share | |||||
| Fixed asset turnover | - | 1.26 | 1.30 | 1.11 | 1.41 |
| Inventory turnover | - | 216.88 | 135.83 | 164.87 | 863.63 |
| Debtors turnover | - | 2.00 | 3.14 | 3.47 | 4.28 |
| EPS (₹) | 11.05 | 11.80 | 82.78 | 3.86 | 41.94 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 34.93 | 209.01 | 126.23 | 122.37 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Revenue | 88.53 | 83.24 | 78.50 | 58.37 | 68.94 |
| Revenue growth | +6.4% | +6.0% | +34.5% | -15.3% | - |
| Other income | 1.00 | 0.29 | 1.19 | 0.15 | 0.18 |
| Total expenses | 55.30 | 54.68 | 55.98 | 52.35 | 54.26 |
| Employee cost | 0.00 | 7.49 | 7.24 | 8.31 | 8.90 |
| EBITDA | 33.23 | 28.56 | 22.52 | 6.02 | 14.68 |
| EBITDA margin | +37.5% | +34.3% | +28.7% | +10.3% | +21.3% |
| Depreciation | 5.93 | 4.96 | 5.24 | 3.34 | 3.51 |
| Interest | 1.97 | 2.55 | 2.46 | 1.96 | 1.94 |
| Profit before tax | 26.33 | 21.34 | 16.01 | 0.87 | 9.41 |
| Tax | 7.00 | 5.42 | 3.66 | 0.30 | 3.09 |
| Net profit | 19.33 | 15.92 | 11.59 | 0.57 | 6.31 |
| Net profit margin | +21.8% | +19.1% | +14.8% | +1.0% | +9.2% |
| EPS (₹) | 11.09 | 11.79 | 82.25 | 3.82 | 42.01 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Equity & liabilities | |||||
| Share capital | 17.42 | 13.50 | 1.50 | 1.50 | 1.50 |
| Reserves & surplus | 98.62 | 33.56 | 29.77 | 17.43 | 16.86 |
| Shareholders' funds (net worth) | 116 | 47.06 | 31.27 | 18.93 | 18.36 |
| Secured loans | 5.70 | 13.65 | 11.41 | 10.75 | 11.74 |
| Unsecured loans | 14.97 | 19.09 | 19.22 | 15.81 | 17.78 |
| Total debt | 20.67 | 32.74 | 30.63 | 26.56 | 29.52 |
| Total liabilities | 138 | 80.62 | 62.70 | 46.30 | 48.56 |
| Assets | |||||
| Gross block | 78.69 | 68.46 | 64.35 | 56.41 | 49.11 |
| Net block | 25.22 | 20.93 | 21.72 | 19.02 | 15.06 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Inventories | 0.38 | 0.24 | 0.53 | 0.63 | 0.08 |
| Sundry debtors | 49.87 | 50.69 | 32.58 | 17.58 | 16.16 |
| Cash & bank balances | 51.51 | 5.14 | 15.44 | 2.18 | 8.97 |
| Loans & advances | 12.88 | 10.89 | 4.39 | 5.56 | 6.30 |
| Total current assets | 115 | 66.96 | 52.94 | 25.95 | 31.51 |
| Total current liabilities | 14.60 | 16.21 | 17.57 | 13.56 | 8.39 |
| Net working capital | 100 | 50.75 | 35.37 | 12.39 | 23.12 |
| Total assets | 138 | 80.62 | 62.70 | 46.30 | 48.56 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Opening cash | 5.14 | 15.44 | 2.18 | 8.97 | 5.71 |
| Net cash from operating activities | 23.44 | (2.49) | 18.25 | 6.47 | 14.39 |
| Net cash from investing activities | (12.75) | (7.44) | (6.87) | (8.57) | (4.14) |
| Net cash from financing activities | 35.67 | (0.37) | 1.89 | (4.70) | (6.99) |
| Net change in cash | 46.36 | (10.30) | 13.27 | (6.80) | 3.26 |
| Closing cash | 51.51 | 5.14 | 15.44 | 2.18 | 8.97 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Growth | |||||
| Sales growth | +6.4% | +6.0% | +34.5% | -15.3% | - |
| EBITDA growth | +16.4% | +26.8% | +274.1% | -59.0% | - |
| PBT growth | +23.4% | +33.3% | +1740.2% | -90.8% | +9997.0% |
| Net income growth | +21.4% | +37.4% | +1933.3% | -91.0% | - |
| Revenue CAGR (3Y) | +14.9% | +6.5% | - | - | - |
| EBITDA CAGR (3Y) | +76.7% | +24.8% | - | - | - |
| Profitability & leverage | |||||
| Net income margin | +21.8% | +19.1% | +15.7% | +1.0% | +9.2% |
| Return on capital employed | - | +33.3% | +33.9% | +6.0% | +23.3% |
| Return on net worth | - | +40.6% | +49.2% | +3.1% | +34.3% |
| Debt / equity | - | 0.81 | 1.14 | 1.50 | 1.61 |
| Long-term debt / equity | - | 0.39 | 0.60 | 0.83 | 0.90 |
| Interest cover | 7.22 | 10.81 | 14.24 | 73.13 | 17.37 |
| Efficiency & per share | |||||
| Fixed asset turnover | - | 1.25 | 1.30 | 1.11 | 1.40 |
| Inventory turnover | - | 216.21 | 135.34 | 164.42 | 861.75 |
| Debtors turnover | - | 2.00 | 3.13 | 3.46 | 4.27 |
| EPS (₹) | 11.09 | 11.79 | 82.25 | 3.82 | 42.01 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 34.86 | 208.46 | 126.21 | 122.38 |
To see the full year-wise statements and ratios of Star Imaging and Path Lab Limited, buy the company report.
Board of directors of Star Imaging and Path Lab Limited
Star Imaging and Path Lab has 7 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pawan Gupta | Managing Director | 31 May 2004 | 22 Years 5 Months | Current |
| Neelam Ratra | Director | 16 Jun 2025 | 1 Years 5 Months | Current |
| Dikshant Nagpal Also directs: Star Forresta LLP, Futurity Sustainable Foods Private Limited, Unilync Soft-Tech Private Limited and 1 more | Director | 30 Nov 2024 | 1 Years 11 Months | Current |
| Vimal Gupta Also directs: Sunrise Heritage LLP, Abyss Pharma Private Limited | Director | 01 Jul 2024 | 2 Years 4 Months | Current |
| Yogesh Kumar Virmani | Director | 01 Jul 2024 | 2 Years 4 Months | Current |
| Sameer Sood | Director | 27 Sep 2024 | 2 Years 1 Months | Current |
Peer comparison
Star Imaging and Path Lab Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Star Imaging and Path Lab Limitedthis company | ₹88.53 Cr (FY 2026) | ₹19.29 Cr | 21.8% | 6.0% | New Delhi, Delhi, India | |
| Atulaya Healthcare Private Limited | ₹85.65 Cr (FY 2024) | 21.0% | Chandigarh, India | |||
| Pulse Diagnostics Private Limited | ₹80.71 Cr (FY 2024) | 27.0% | Kolkata, West Bengal, India | |||
| Sanghi Medical Centre Private Limited | ₹77.91 Cr (FY 2025) | 16.0% | New Delhi, Delhi, India |
To see the full peer comparison of Star Imaging and Path Lab Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Apr 2026 | 101296921 | Hdfc Bank Limited | ₹22.92 Lakh | Open | |
| 24 Sep 2025 | 101167608 | Hdfc Bank Limited | ₹11.46 Lakh | Open | |
| 02 May 2025 | 101097091 | Hdfc Bank Limited | ₹13.71 Lakh | Open | |
| 24 Mar 2025 | 101079046 | Others | ₹4.32 Cr | Open | |
| 15 Sep 2023 | 100820949 | Hdfc Bank Limited | ₹7.6 Lakh | Open |
To see the full charge records of Star Imaging and Path Lab Limited, buy the company report.
Total charge records: 28 View all charges
Deals & funding
Star Imaging and Path Lab Limited has 9 deals on record (3 secondary share transfers, 3 market trades, 2 funding rounds), with disclosed funding of ₹1.49 Cr; the latest was in June 2026.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2026 | Market trade | ₹90.5 Lakh | Buyer: an individual |
| Sep 2025 | Market trade | ₹2.9 Cr | Seller: Strategic Sixth Sense Capital Fund |
| Aug 2025 | Market trade | ₹3.29 Cr | Buyer: Share India Securities Limited, Achintya Securities Limited Seller: Share India Securities Limited |
| Aug 2025 | IPO | ₹69.47 Cr | Investors: Mili Capital Investement, Compact Structure Fund, Persistent Growth Fund Seller: an individual |
| Jul 2025 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Star Imaging and Path Lab Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Star Imaging and Path Lab Limited has 5 court cases on record: 4 filed by Star Imaging and Path Lab, 1 filed against it. 1 case is pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 1 | 1 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Criminal case | Filed by the company against Ugam Healthcare Pvt Ltd | Pending |
| District court, South West, Delhi | Cheque dishonour complaint | Filed by the company against Ugam Healthcare Pvt. Ltd. | Disposed |
| District court, West, Delhi | Civil suit | Filed against the company by A-One Copier Services Pvt Ltd | Disposed |
| District court, Central, Delhi | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
| District court, Central, Delhi | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
To see the full case history of Star Imaging and Path Lab Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Star Imaging and Path Lab Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Star Imaging and Path Lab has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Star Imaging and Path Lab Limited, buy the company report.
Recent activity
Star Imaging and Path Lab Limited has 19 board changes on record since 2004: 7 appointments and 12 cessations. The latest: Neelam Ratra ceased to be Additional Director on 24 Jun 2025.
60 earlier events are in the company report.
News
Frequently asked questions
Star Imaging and Path Lab is an active public limited company based in New Delhi, Delhi, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 31 May 2004 (22+ years old) and is registered under CIN L85110DL2004PLC126679. Listed on BSE: 544482.
Star Imaging and Path Lab reported revenue of ₹88.53 Cr for FY 2025-26 (up 6% YoY) based on consolidated financials.
Star Imaging and Path Lab has 7 current directors:
- Pawan Gupta - Managing Director
- Neelam Ratra - Director
- Dikshant Nagpal - Director
- Vimal Gupta - Director
- Yogesh Kumar Virmani - Director
- Sameer Sood - Director
- Chhaya Gupta - Director
The latest financial statements of Star Imaging and Path Lab on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 24 July 2025. Year-wise statements from 2015 are in the company report.
No. Star Imaging and Path Lab has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Star Imaging and Path Lab is L85110DL2004PLC126679. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Star Imaging and Path Lab is a listed company as per MCA records. Its shares are listed on BSE (code: 544482).
Star Imaging and Path Lab has 5 court cases on record: 4 filed by the company and 1 filed against it. 1 is pending.
Star Imaging and Path Lab was incorporated on 31 May 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
Star Imaging and Path Lab has 9 deals on record (3 secondary share transfers, 3 market trades, 2 funding rounds), with disclosed funding of ₹1.49 Cr; the latest was in June 2026.
The peers of Star Imaging and Path Lab by revenue are Atulaya Healthcare Private Limited, Pulse Diagnostics Private Limited, Sanghi Medical Centre Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).

